PLUS1
Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Repros Therapeutics Inc. (delisted) | RPRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| +0 | +0% | 0.67 | - | - | - | 0.67 | 02:05:03 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.66 | 0.6725 | 0.0125 | 1.86% | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | - | - | USD |
Repros Therapeutics Inc. (delisted) Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 25.2M | 37.62M | $ -17.27M | -0.70 | 0.00 | 37.23M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 0.00 | 0.00% | - | 19.00% |
Repros Therapeutics Inc. (delisted) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 2/13/2018 | 10:06 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) |
| 2/09/2018 | 10:25 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under.. |
| 2/07/2018 | 06:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) |
| 2/07/2018 | 06:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) |
| 2/07/2018 | 06:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) |
| 2/07/2018 | 06:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) |
| 2/07/2018 | 06:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RPRX Price Data
There is no data to display
Repros Therapeutics Inc. (delisted) Description
| Repros Therapeutics Inc. is development stage biopharmaceutical company focused on the development of oral small molecule drugs for major unmet medical needs in male and female health. |
